Abbott supported its CE mark approval with data from its FOCALFLEX CE mark study. The global clinical trial, conducted across ...
ST. LOUIS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback